GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers

BusinesswireJan 9 21:30

GeneDx Continues Its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients

BusinesswireJan 8 21:30

GeneDx Shares Are Trading Higher After TD Cowen Raised Its Price Target From $75 to $118.

BenzingaJan 8 02:45

GeneDx Hldgs Analyst Ratings

BenzingaJan 8 00:56 · Ratings

TD Cowen Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $118

Futu NewsJan 7 19:31 · Ratings

TD Cowen Reaffirms Their Buy Rating on GeneDx Holdings (WGS)

TipRanksJan 7 19:19 · Ratings